PulseExploreJournal ClubDebatesTrendingResearchersJournals
Instagram
HomeExploreJournal ClubTrending
Synapse
⌘+K
Synapse
March 15, 20240 citationsOpen Access

Addressing Depression and Comorbid Health Conditions through Solution-Focused Brief Therapy in an Integrated Care Setting: A Randomized Clinical Trial

View Full Paper
ZCZachary CooperEmory UniversityOMOrion MowbrayUniversity of GeorgiaMAMohammed K. AliPreventive Cardiology

Key Points

Key points are not available for this paper at this time.

Abstract

Abstract Background: Co-occurring physical and mental health conditions are common, but effective and sustainable interventions are needed for primary care settings. Purpose: Our paper analyzes the effectiveness of a Solution-Focused Brief Therapy (SFBT) Intervention for treating depression and co-occurring health conditions in primary care. Methods: A Randomized Clinical Trial was conducted at a rural federally qualified health center. Eligible participants scored ≥10 on the Patient Health Questionnaire (PHQ-9) and met criteria for co-occurring health conditions (hypertension, obesity, diabetes) evidenced by chart review. SFBT participants (n=40) received three SFBT interventions over three weeks in addition to treatment as usual (TAU). The control group (n=40) received TAU over three weeks. Measures included depression (PHQ-9) and anxiety (GAD-7), well-being (Human Flourishing Index), and SFBT scores, along with physical health outcomes. Results: Of 80 consented participants, 69 completed all measures and were included in the final analysis. 80% identified as female and the mean age was 38.1 (SD 14.5). Most participants were White (72%) followed by Hispanic (15%) and Black (13%). When compared to TAU, SFBI participants had significant reductions in depression (baseline: M=18.17, SD=3.97, outcome: (M=9.71, SD=3.71) and anxiety (baseline: M=14.69, SD=4.9, outcome: M=8.43, SD= 3.79). SFBI participants also had significantly increased flourishing scores (baseline: M=58.37, SD= 16.36, outcome: M=73.43, SD= 14.70) when compared to TAU. Changes in BMI and blood pressure were not statistically significant. Conclusions: SFBI demonstrated efficacy in reducing depressive and anxiety symptoms and increasing well-being. Trial Registration: The study was pre-registered at ClinicalTrials.gov Identifier: NCT05838222 on 4/20/2023.

Ask AI
Helpful
Bookmark
Share
View Full Paper

Cite This Study

Cooper et al. (2024) studied this question.

synapsesocial.com/papers/68e73ec2b6db6435876b8033https://doi.org/10.21203/rs.3.rs-3996940/v1
Ask AI
Helpful
Bookmark
Share
View Full Paper